Wolwo Bio-Pharmaceutical: Share transfer and reduction plan revealed

Zhejiang Wolwo Bio-Pharmaceutical (SZSE:300357) disclosed plans for its controlling shareholder, Zhejiang Wolwo Management Consulting Co., Ltd., to transfer up to 4,500,000 shares (0.86% of total equity) to Mr. Hu Gengxi, the company's actual controller, through block trading. This transfer is driven by Zhejiang Wolwo Management Consulting’s funding needs. Additionally, Director and Deputy General Manager Ms. Zhang Lu intends to reduce her holdings by no more than 300,000 shares (0.06% of total equity) via centralized bidding, citing personal funding needs. The transfer and reduction plans will commence 15 trading days after the announcement date and extend for three months, and the transfer price will be determined by the market. Post-transfer, the combined shareholding of Hu Gengxi and YANNI CHEN, the co-actual controllers, will remain unchanged, ensuring no shift in control.